tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook for Kura Oncology Driven by Promising Clinical Trials and Strategic Advancements
PremiumRatingsPositive Outlook for Kura Oncology Driven by Promising Clinical Trials and Strategic Advancements
2M ago
Kura Oncology, Kyowa Kirin report combination data for KOMZIFTI with ven/aza
Premium
The Fly
Kura Oncology, Kyowa Kirin report combination data for KOMZIFTI with ven/aza
2M ago
Kura Oncology Announces First U.S. Sale of KOMZIFTI
Premium
Company Announcements
Kura Oncology Announces First U.S. Sale of KOMZIFTI
2M ago
FDA Calendar: These Are the Upcoming FDA Drug Approvals 
PremiumMarket NewsFDA Calendar: These Are the Upcoming FDA Drug Approvals 
2M ago
Kura Oncology price target raised to $30 from $29 at BofA
Premium
The Fly
Kura Oncology price target raised to $30 from $29 at BofA
3M ago
Kura Oncology price target raised to $38 from $36 at Wedbush
Premium
The Fly
Kura Oncology price target raised to $38 from $36 at Wedbush
3M ago
Kura Oncology, Kyowa Kirin announce FDA approval of KOMZIFTI for AML
PremiumThe FlyKura Oncology, Kyowa Kirin announce FDA approval of KOMZIFTI for AML
3M ago
FDA announces approval of Kura’s Komzifti for AML
Premium
The Fly
FDA announces approval of Kura’s Komzifti for AML
3M ago
Kura Oncology trading halted, news pending
Premium
The Fly
Kura Oncology trading halted, news pending
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100